Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Social Stream
JAZZ PHARMACEUTICALS PLC (JAZZ) Price Targets From Analysts
Use the tables below to see what analysts covering JAZZ PHARMACEUTICALS PLC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-10 | 15 | $250 | $172 | $204.937 | $156.66 | 30.82% |
2021-11-11 | 15 | $250 | $172 | $204.312 | $156.66 | 30.42% |
2021-11-16 | 15 | $250 | $172 | $204.125 | $156.66 | 30.3% |
2021-12-17 | 14 | $250 | $172 | $203.812 | $156.66 | 30.1% |
2021-12-20 | 14 | $250 | $172 | $201.937 | $156.66 | 28.9% |
2022-01-06 | 14 | $250 | $172 | $202.312 | $156.66 | 29.14% |
2022-01-13 | 14 | $250 | $172 | $202.812 | $156.66 | 29.46% |
2022-01-23 | 14 | $250 | $172 | $204.562 | $156.66 | 30.58% |
2022-02-11 | 12 | $250 | $172 | $204.437 | $156.66 | 30.5% |
2022-02-25 | 11 | $250 | $172 | $204.437 | $156.66 | 30.5% |
2022-03-02 | 12 | $250 | $172 | $202.866 | $156.66 | 29.49% |
2022-03-04 | 14 | $250 | $172 | $202.266 | $156.66 | 29.11% |
2022-03-28 | 14 | $250 | $174 | $203.466 | $156.66 | 29.88% |
2022-04-22 | 14 | $250 | $174 | $204.357 | $156.66 | 30.45% |
2022-04-28 | 14 | $250 | $174 | $203.785 | $156.66 | 30.08% |
2022-05-06 | 14 | $250 | $174 | $205.285 | $156.66 | 31.04% |
2022-06-02 | 15 | $250 | $174 | $203.666 | $156.66 | 30.01% |
2022-06-14 | 16 | $250 | $174 | $203.062 | $156.66 | 29.62% |
2022-08-01 | 15 | $225 | $174 | $199.933 | $156.66 | 27.62% |
2022-09-17 | 16 | $225 | $183 | $200.437 | $156.66 | 27.94% |
2022-09-21 | 16 | $225 | $148 | $197.437 | $156.66 | 26.03% |
2022-09-29 | 15 | $225 | $170 | $197.312 | $156.66 | 25.95% |
2022-10-20 | 14 | $225 | $170 | $196.933 | $156.66 | 25.71% |
2022-11-02 | 14 | $225 | $170 | $197.133 | $156.66 | 25.83% |
2022-11-30 | 16 | $225 | $180 | $199.437 | $156.66 | 27.31% |
2022-12-14 | 16 | $225 | $180 | $199.312 | $156.66 | 27.23% |
2023-01-23 | 16 | $225 | $180 | $200.25 | $156.66 | 27.82% |
2023-01-27 | 16 | $225 | $180 | $200.125 | $156.66 | 27.74% |
The Trend in the Analyst Price Target
JAZZ's average price target has moved up $46.12 over the prior 32 months.
JAZZ reports an average of 36.41% for its upside potential over the past 50 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-04-21 | 14 | 250 | 174 | 204.357 | 165.55 | 23.44% |
2022-04-28 | 14 | 250 | 174 | 203.785 | 161.19 | 26.43% |
2022-07-11 | 15 | 225 | 174 | 199.933 | 155.63 | 28.47% |
2022-08-13 | 16 | 225 | 183 | 200.437 | 157.08 | 27.6% |
2022-09-29 | 14 | 225 | 170 | 198.812 | 132.42 | 50.14% |
JAZZ Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.25 | 13 | 2 | 1 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
Over the past 13 months, JAZZ's average broker recommendation rating worsened by 0.04.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, JAZZ PHARMACEUTICALS PLC's average analyst price target is greater than 3479.92% of them.
- In the context of Pharmaceutical Products stocks, JAZZ PHARMACEUTICALS PLC's number of analysts covering the stock is higher than 3483.51% of them.
- JAZZ has a lower variance in analysts' estimates than -737.36% of Pharmaceutical Products stocks.
- JAZZ has a higher upside potential (average analyst target price relative to current price) than 859.68% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, ALNY, UTHR, and BMRN are the three stocks most similar to JAZZ PHARMACEUTICALS PLC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding JAZZ using the data that counts. Try POWR Ratings for free.